Article Details

Hinge Bio: $30 Million (Series A) To Develop Therapies For Autoimmune Disease

Retrieved on: 2025-01-26 01:36:41

Tags for this article:

Click the tags to see associated articles and topics

Hinge Bio: $30 Million (Series A) To Develop Therapies For Autoimmune Disease. View article details on hiswai:

Excerpt

The therapeutic goal of HB2198 is to achieve a reset of the immune system through rapid and deep B cell depletion in peripheral blood and lymphoid ...

Article found on: pulse2.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo